Liver Biopsy for Histological Assessment: The Case in Favor

Alswat, Khalid A.; Mumtaz, Khalid; Jafri, Wasim
April 2010
Saudi Journal of Gastroenterology;Apr2010, Vol. 16 Issue 2, p133
Academic Journal
Liver biopsy (LB) is the gold standard method for assessment of liver histology. It provides valuable, otherwise unobtainable information, regarding the degree of fibrosis, parenchymal integrity, degree and pattern of inflammation, bile duct status and deposition of materials and minerals in the liver. This information provides immense help in the diagnosis and prognostication of a variety of liver diseases. With careful selection of patients, and performance of the procedure appropriately, the complications become exceptionally rare in current clinical practice. Furthermore, the limitations of sampling error and inter-/ intra-observer variability may be avoided by obtaining adequate tissue specimen and having it reviewed by an experienced liver pathologist. Current noninvasive tools are unqualified to replace LB in clinical practice in the face of specific limitations for each tool, compounded by a poorer performance towards the assessment of the degree of liver fibrosis, particularly for intermediate stages.


Related Articles

  • Liver Biopsy for Histological Assessment -- The Case Against. Sanai, Faisal M.; Keeffe, Emmet B. // Saudi Journal of Gastroenterology;Apr2010, Vol. 16 Issue 2, p124 

    Percutaneous liver biopsy (LB) remains an important tool in the diagnosis and management of parenchymal liver diseases. In current practice, it is most frequently performed to assess the inflammatory grade and fibrotic stage of commonly encountered liver diseases, with the diagnostic role...

  • Assessment of Liver Fibrosis: Noninvasive Means. Poynard, Thierry; Morra, Rachel; Ingiliz, Patrick; Imbert-Bismut, Françoise; Thabut, Dominique; Messous, Djamila; Munteanu, Mona; Massard, Julien; Benhamou, Yves; Ratziu, Vlad // Saudi Journal of Gastroenterology;Oct2008, Vol. 14 Issue 4, p163 

    Liver biopsy, owing to its limitations and risks, is an imperfect gold standard for assessing the severity of the most frequent chronic liver diseases chronic hepatitis C (HCV), B (HBV) non alcoholic (NAFLD) and alcoholic (ALD) fatty liver diseases. This review summarizes the advantages and the...

  • Serum Hyaluronic Acid as a Noninvasive Marker of Hepatic Fibrosis in Chronic Hepatitis B. Geramizadeh, Bita; Janfeshan, Katayoun; Saberfiroozi, Mehdi // Saudi Journal of Gastroenterology;Oct2008, Vol. 14 Issue 4, p174 

    Background/Aims: Chronic hepatitis B is a serious global health problem. Liver biopsy is currently recommended as the gold standard for the evaluation of the degree of fibrosis in patients with chronic hepatitis B. This procedure, however, is invasive and has potential complications. In this...

  • The ELF panel: a new crystal ball in hepatology? Pinzani, Massimo // Gut;Sep2010, Vol. 59 Issue 9, p1165 

    The article discusses the use of non-invasive methods as cross-sectional discriminators of the fibrotic progression and major stages of chronic liver diseases (CLD). Examples of non-invasive methods for use in clinical practice are serum markers and transient elastography. Data also shows that...

  • Non-invasive assessment of liver fibrosis. Papastergiou, Vasilios; Tsochatzis, Emmanuel; Burroughs, Andrew K. // Annals of Gastroenterology;Jul-Sep2012, Vol. 25 Issue 3, p218 

    The presence and degree of hepatic fibrosis is crucial in order to make therapeutic decisions and predict clinical outcomes. Currently, the place of liver biopsy as the standard of reference for assessing liver fibrosis has been challenged by the increasing awareness of a number of drawbacks...

  • Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice. Armstrong, M. J.; Corbett, C.; Hodson, J.; Marwah, N.; Parker, 4. R.; Houlihan, D. D.; Rowe, I. A.; Hazlehurst, J. M.; Brown, R.; Hübscher, S. G.; Mutimer, D. // Postgraduate Medical Journal;Dec2013, Vol. 89 Issue 1058, p685 

    Background Fibroscan is a quick, non-invasive technique used to measure liver stiffness (kPa), which correlates with fibrosis. To achieve a valid liver stiffness evaluation (LSE) the operator must obtain all the following three criteria: (1) ≥10 successful liver stiffness measurements; (2)...

  • Assessment of Liver Fibrosis With New Modalities. Nichols, Emma Hitt; Afdhal, Nezam H. // MD Conference Express;Jul2015, Vol. 15 Issue 14, p5 

    Although liver biopsy is considered the gold standard method of assessment for liver fibrosis, it is being displaced by noninvasive testing, such as serum biomarkers, vibration-controlled transient elastography, magnetic resonance elastography, and acoustic radiation force impulse. However, it...

  • Pediatric Liver MR Elastography. Serai, Suraj; Towbin, Alexander; Podberesky, Daniel // Digestive Diseases & Sciences;Oct2012, Vol. 57 Issue 10, p2713 

    Introduction: Many chronic pediatric liver disorders are complicated by the development of fibrosis and ultimately cirrhosis. Although hepatic fibrogenesis progresses along a common pathway irrespective of the specific etiology, fibrosis in pediatric liver diseases has different...

  • Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort. Holmberg, Scott D.; Lu, Mei; Rupp, Loralee B.; Lamerato, Lois E.; Moorman, Anne C.; Vijayadeva, Vinutha; Boscarino, Joseph A.; Henkle, Emily M.; Gordon, Stuart C. // Clinical Infectious Diseases;Jul2013, Vol. 57 Issue 2, p240 

    Authors review 2 (FIB-4 and APRI) systems relying on more easily obtainable serum and cell biomarkers for liver biopsies to stage liver disease. This would be an important step in opening treatment and care of uncomplicated hepatitis C virus–infected patients.Background. Liver biopsy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics